Literature DB >> 3133812

Fibrinolysis in normal subjects--comparison between plasminogen activator inhibitor and other components of the fibrinolytic system.

G Nicoloso1, J Hauert, E K Kruithof, G Van Melle, F Bachmann.   

Abstract

We analyzed fibrinolytic parameters in 20 healthy men and 20 healthy women, aged from 25 to 59, before and after 10 and 20 min venous occlusion. The 10 min post-occlusion fibrinolytic activity measured directly in diluted unfractionated plasma by a highly sensitive 125I-fibrin plate assay correlated well with the activity of euglobulins determined by the classical fibrin plate assay (r = 0.729), but pre-stasis activities determined with these two methods did not correlate (r = 0.084). The enhancement of fibrinolytic activity after venous occlusion was mainly due to an increase of t-PA in the occluded vessels (4-fold increase t-PA antigen after 10 min and 8-fold after 20 min venous occlusion). Plasminogen activator inhibitor (PAI) activity and plasminogen activator inhibitor 1 (PAI-1)1 antigen levels at rest showed considerable dispersion ranging from 1.9 to 12.4 U/ml, respectively 6.9 to 77 ng/ml. A significant increase of PAI-1 antigen levels was observed after 10 and 20 min venous occlusion. At rest no correlation was found between PAI activity or PAI-1 antigen levels and the fibrinolytic activity measured by 125I-FPA. However, a high level of PAI-1 at rest was associated with a high prestasis antigen level of t-PA and a low fibrinolytic response after 10 min of venous stasis. Since the fibrinolytic response inversely correlated with PAI activity at rest, we conclude that its degree depends mainly on the presence of free PAI.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3133812

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  6 in total

1.  The fibrinolytic effects of intermittent pneumatic compression: mechanism of enhanced fibrinolysis.

Authors:  A J Comerota; V Chouhan; R N Harada; L Sun; J Hosking; R Veermansunemi; A J Comerota; D Schlappy; A K Rao
Journal:  Ann Surg       Date:  1997-09       Impact factor: 12.969

2.  Catheter directed compared to systemically delivered thrombolysis for pulmonary embolism: a systematic review and meta-analysis.

Authors:  Ahmed K Pasha; Muhammad Umer Siddiqui; Muhammad Danial Siddiqui; Adnan Ahmed; Ammar Abdullah; Irbaz Riaz; M Hassan Murad; Haraldur Bjarnason; Waldemar E Wysokinski; Robert D McBane
Journal:  J Thromb Thrombolysis       Date:  2021-08-31       Impact factor: 2.300

3.  The urokinase plasminogen activator (u-PA) and its inhibitor (PAI-1) in embryo-fetal bone formation in the human: an immunohistochemical study.

Authors:  C Häckel; K Radig; I Röse; A Roessner
Journal:  Anat Embryol (Berl)       Date:  1995-10

4.  Prothrombotic abnormalities in inflammatory bowel disease.

Authors:  M G Conlan; W D Haire; D A Burnett
Journal:  Dig Dis Sci       Date:  1989-07       Impact factor: 3.199

Review 5.  Coagulation complications following trauma.

Authors:  Wenjun Z Martini
Journal:  Mil Med Res       Date:  2016-11-22

Review 6.  Tissue-type plasminogen activator is a neuroprotectant in the central nervous system.

Authors:  Manuel Yepes
Journal:  Front Cell Neurosci       Date:  2015-08-17       Impact factor: 5.505

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.